N
NervGen Pharma Corp. (NGEN)
NCM – Real Time Price. Currency in USD
1.92
+0.03 (1.59%)
At close: Jun 12, 2026, 4:00 PM EDT
2.00
+0.08 (4.17%)
Pre-market: Jun 15, 2026, 7:04 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.92
+0.03 (1.59%)
At close: Jun 12, 2026, 4:00 PM EDT
2.00
+0.08 (4.17%)
Pre-market: Jun 15, 2026, 7:04 AM EDT
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company’s lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer’s disease; and NVG-300, which is in a preclinical model of ischemic stroke, amyotrophic lateral sclerosis, and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.
| Name | Position |
|---|---|
| Dr. Keith A. Vendola M.B.A., M.D. | Chief Financial Officer |
| Dr. Randall E. Kaye M.D. | Chief Medical Advisor & Director |
| Ms. Christine McSherry | Senior Vice President of Patient Advocacy & Clinical Affairs |
| Ms. Shamim Ruff M.S. | Chief Regulatory Affairs Officer |
| Date | Type | Document |
|---|---|---|
| 2026-06-01 | 6-K | tm2616544d1_6k.htm |
| 2026-05-26 | SUPPL | tm2615031d2_suppl.htm |
| 2026-05-22 | 6-K | tm2615291d1_6k.htm |
| 2026-05-21 | SUPPL | tm2615031d1_suppl.htm |
| 2026-05-18 | 6-K | tm2614980d1_6k.htm |
| 2026-05-15 | 6-K | tm2614733d1_6k.htm |
| 2026-05-07 | S-8 | tm2613338d1_s8.htm |
| 2026-04-27 | 6-K | tm2612795d1_6k.htm |
| 2026-03-31 | 40-F | tmb-20251231x40f.htm |
| 2026-03-13 | 6-K | tm268804d1_6k.htm |